Clinical Depression


Approximately 1 in 6 people will suffer major depression at one point in their lives, and while there are various antidepressants on the market, many patients remain severely undertreated.

Current first-line therapies take between 3 and 12 weeks to work, and it is often during this long lag-time that the most debilitating symptoms of depression occur. In addition, around 40% of patients remain clinically ill after a year of treatment, highlighting the urgent need for alternative therapies. 

We have identified an innovative solution to bridge this gap by developing a rapid-acting antidepressant.